TrademarkDir
EPIDIOLEX
LIVE

Serial Number

86007888

Owner

GW Research Limited

Attorney

Michael T. Olsen

Filing Date

Jul 11, 2013

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

EPIDIOLEX Trademark

Serial Number: 86007888 • Registration: 4484943

EPIDIOLEX is a trademark filed by GW Research Limited on July 11, 2013. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

GW Research Limited (77 trademarks)

Sovereign House,

Entity Type: 98

GW Pharma Limited (40 trademarks)

Sovereign House, Histon

Entity Type: 03

Jazz Pharmaceuticals Research UK Limited (46 trademarks)

Building 730,

Entity Type: 98

Trademark Details

Filing Date

July 11, 2013

Registration Date

February 18, 2014

Published for Opposition

December 3, 2013

Goods & Services

Pharmaceutical and [ veterinary preparations and ] substances for the treatment of epilepsy, convulsions, seizures, Dravet syndrome, Lennox-Gastaut syndrome, intractable childhood epilepsy with generalized tonic-clonic seizures, generalized epilepsy with febrile seizures plus, [ Doose syndrome and chromosome disorders; ] pharmaceutical preparations and substances for the treatment of pediatric epilepsy; [ herbs for medicinal purposes; medicinal herbs; medicinal oils; medicinal infusions for the treatment of epilepsy; ] pure extracts of medicinal plants and herbs used for the treatment of epilepsy, convulsions and seizures; [ herb teas for medicinal purposes ]

Filing History

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Feb 24, 2025 ASGN
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
May 29, 2024 NA89
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
May 29, 2024 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
May 29, 2024 89AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 29, 2024 APRE
TEAS SECTION 8 & 9 RECEIVED
Feb 16, 2024 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Feb 18, 2023 REM2
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 15, 2021 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Sep 15, 2021 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 15, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 15, 2021 REAP
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Jul 28, 2021 ASCK
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Oct 6, 2020 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Oct 6, 2020 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Oct 6, 2020 APRE
TEAS SECTION 8 & 15 RECEIVED
Aug 16, 2020 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Feb 18, 2019 REM1
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jul 25, 2018 ASGN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 12, 2017 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Dec 12, 2017 COAR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 29, 2017 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 29, 2017 REAP
REGISTERED-PRINCIPAL REGISTER
Feb 18, 2014 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 3, 2013 NPUB
PUBLISHED FOR OPPOSITION
Dec 3, 2013 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 13, 2013 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Oct 31, 2013 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 30, 2013 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 28, 2013 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 28, 2013 CRFA
ASSIGNED TO LIE
Oct 24, 2013 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 21, 2013 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 19, 2013 GNRN
NON-FINAL ACTION E-MAILED
Sep 19, 2013 GNRT
NON-FINAL ACTION WRITTEN
Sep 19, 2013 CNRT
ASSIGNED TO EXAMINER
Sep 15, 2013 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 19, 2013 NWOS
NEW APPLICATION ENTERED
Jul 15, 2013 NWAP

Related Trademarks

More from this Owner

EPIFOS

EPIFOS

EPIDYOLEX

EPIDYOLEX

LIVING WITH

LIVING WITH

LIVING WITH

LIVING WITH

IMPACT INNOVATIVE MEDICAL PERSPECTIVES, ADVANCING CANNABIDIOL TREATMENT logo

IMPACT INNOVATIVE MEDICAL PERSPECTIVES, ADVANCING CANNABIDIOL TREATMENT

IMPACT INNOVATIVE MEDICAL PERSPECTIVES, ADVANCING CANNABIDIOL TREATMENT logo

IMPACT INNOVATIVE MEDICAL PERSPECTIVES, ADVANCING CANNABIDIOL TREATMENT